Showing results (1781-1790 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|November 20, 2016
The Harms of Antipsychotic Drugs: Evidence from Key StudiesThomas J Moore, Curt D Furberg
Drug Safety|December 19, 2016
Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in FranceMarine Auffret, Julien Labreuche, Alain Duhamel, et al.
Drug Safety|October 11, 2016
From the Uppsala Monitoring Centre : A Review of Viewpoint Part 1 and Part 2Bruce Hugman
Drug Safety|December 23, 2016
Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a TollGuillermo Prada-Ramallal, Bahi Takkouche, Adolfo Figueiras
Drug Safety|March 22, 2017
Targeting Interleukin-5 or Interleukin-5Rα: Safety ConsiderationsDiego Bagnasco, Matteo Ferrando, Marco Caminati, et al.
Drug Safety|April 7, 2017
Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian HospitalsNibu Parameswaran Nair, Leanne Chalmers, Bonnie J Bereznicki, et al.
Drug Safety|March 22, 2014
Application of a self-controlled case series study to a database study in childrenHanae Ueyama, Shiro Hinotsu, Shiro Tanaka, et al.
Drug Safety|January 12, 2017
Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge RetentionNancy A Brandenburg, Robert Bwire, John Freeman, et al.
Drug Safety|February 27, 2017
Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of JustificationIgho J Onakpoya, Carl J Heneghan, Jeffrey K Aronson
Drug Safety|March 10, 2017
Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden DeathRaymond L Woosley, Klaus Romero, Craig W Heise, et al.
Pageof 309